Provided by Tiger Trade Technology Pte. Ltd.

Gain Therapeutics, Inc.

1.91
-0.0950-4.75%
Post-market: 1.940.0350+1.84%19:45 EDT
Volume:383.42K
Turnover:755.26K
Market Cap:83.14M
PE:-3.74
High:2.05
Open:2.00
Low:1.90
Close:2.00
52wk High:4.34
52wk Low:1.53
Shares:43.64M
Float Shares:42.34M
Volume Ratio:1.18
T/O Rate:0.91%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.5092
EPS(LYR):-0.6115
ROE:-268.30%
ROA:-95.51%
PB:7.36
PE(LYR):-3.12

Loading ...

Company Profile

Company Name:
Gain Therapeutics, Inc.
Exchange:
NASDAQ
Establishment Date:
2017
Employees:
- -
Office Location:
4800 Montgomery Lane,Suite 220,Bethesda,Maryland,United States
Zip Code:
20814
Fax:
- -
Introduction:
Gain Therapeutics, Inc., a biotechnology company, researches and develops novel therapies to treat diseases caused by protein misfolding in Switzerland and Spain. It focuses on rare genetic diseases and neurological disorders. The company uses its Site-Directed Enzyme Enhancement Therapy platform to discover allosteric sites on misfolded proteins and identify proprietary small molecules that bind these sites, restore protein folding, and treat disease. Its lead product candidate includes GT-02287, for the treatment of GBA1 Parkinson's disease. In addition, the company is developing structurally targeted allosteric regulator candidates to treat various diseases, including Morquio B, GM1 gangliosidosis (GM1), neuronopathic Gaucher disease, GBA1 Parkinson's, Krabbe, and Mucopolysaccharidosis type 1 diseases. Gain Therapeutics, Inc. was founded in 2017 and is headquartered in Bethesda, Maryland.

Directors

Name
Position
Gene Mack
Director,Chief Executive Officer and President
Khalid Islam
Chairman of the Board and Director
Claude Nicaise
Independent Director
Dov Goldstein
Independent Director
Gwen Melincoff
Independent Director
Hans Peter Hasler
Independent Director
Jeffrey Riley
Independent Director

Shareholders

Name
Position
Gene Mack
Director,Chief Executive Officer and President
Gianluca Fuggetta
Senior Vice President Finance and Principal Financial Officer